SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-301611
Filing Date
2017-10-03
Accepted
2017-10-03 08:40:02
Documents
3
Period of Report
2017-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d465335d8k.htm 8-K 31916
2 EX-2.1 d465335dex21.htm EX-2.1 394918
3 EX-99.1 d465335dex991.htm EX-99.1 19859
  Complete submission text file 0001193125-17-301611.txt   447894
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37601 | Film No.: 171116154
SIC: 2836 Biological Products, (No Diagnostic Substances)